Century Therapeutics (IPSC) Amortization of Deferred Charges (2020 - 2023)
Century Therapeutics (IPSC) posted quarterly Amortization of Deferred Charges of $38000.0 for Q2 2023, down 50.0% year-over-year from $76000.0 in Q2 2022, and down 32.14% quarter-over-quarter from $56000.0 in Q1 2023.
Powered by 
Analysis
Century Therapeutics (IPSC) Amortization of Deferred Charges (2020 - 2023) Analysis & Trends
Century Therapeutics (IPSC) has reported Amortization of Deferred Charges for 4 consecutive years, with $38000.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Amortization of Deferred Charges fell 50.0% year-over-year to $38000.0; the TTM figure through Dec 2023 stood at $94000.0 (down 68.46% YoY), while the FY2023 annual figure was $94000.0, down 68.56% from the prior year.
- Amortization of Deferred Charges fell to $38000.0 in Q2 2023 per IPSC's latest filing, from $56000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $78000.0 in Q4 2020 and bottomed at $14000.0 in Q3 2020.
- Historically, Amortization of Deferred Charges has averaged $65750.0 across 4 years, with a median of $76000.0 in 2021.
- Annual changes were most pronounced in 2021 — Amortization of Deferred Charges surged 450.0% — and 2023, when it plunged 50.0%.
- Century Therapeutics' Amortization of Deferred Charges stood at $78000.0 in 2020, then fell by 1.28% to $77000.0 in 2021, then fell by 10.39% to $69000.0 in 2022, then tumbled by 44.93% to $38000.0 in 2023.
- Business Quant data shows IPSC's Amortization of Deferred Charges at $38000.0 in Q2 2023, $56000.0 in Q1 2023, and $69000.0 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Century Therapeutics | 440.37 Mn | 180.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Dec 31, 2022 | 69,000.00 |
| Sep 30, 2022 | 77,000.00 |
| Jun 30, 2022 | 76,000.00 |
| Mar 31, 2022 | 76,000.00 |
| Dec 31, 2021 | 77,000.00 |
| Sep 30, 2021 | 77,000.00 |
| Jun 30, 2021 | 76,000.00 |
| Mar 31, 2021 | 75,000.00 |
| Dec 31, 2020 | 78,000.00 |
| Sep 30, 2020 | 14,000.00 |